Ingenuity Systems Announces Extension and Expansion of Its Licensing Agreement with Merck

Merck will continue to utilize IPA in research and development efforts

REDWOOD CITY, CA – FEBRUARY 13, 2007 – Ingenuity Systems today announced that it has entered a multi-year agreement with Merck to extend and expand its licensing agreement for access to IPA software. Merck’s research and development teams will utilize IPA for biological exploration, interpretation and analysis.

“Merck scientists have worked with Ingenuity Pathway Analysis since 2004,” stated Peter DiLaura, SVP, Commercial Operations, at Ingenuity. “IPA has been fully integrated into their R&D process and functionally executed by the compound profiling group and biologists in multiple therapeutic areas. The expansion of our licensing agreement demonstrates Merck’s commitment to solutions that help researchers rapidly derive biological meaning from their complex data.”

IPA is a software application that enables researchers to model, analyze and understand the complex biological systems at the core of life science research. IPA is deployed in all major pharmaceutical companies and hundreds of biotechnology companies and academic institutions globally. It supports analysis of all high throughput analysis platforms and is used in virtually all areas of drug discovery and development from target identification and validation to biomarkers, predictive toxicology and pharmacogenomics.

The Ingenuity Pathways Knowledge Base is a database of biological interactions and functional annotations created from millions of individually modeled relationships between proteins, genes, complexes, cells, tissues, drugs, and diseases. The Ingenuity Pathways Knowledge Base is the largest database of its kind with the most descriptive structure, highest degree of accuracy, and largest number of literature findings.

IPA is available as a web-delivered, hosted, or deployed solution. Fully functional complimentary trials are available at

About Ingenuity Systems®

Ingenuity enables researchers to model, analyze and understand complex biological systems foundational to human health and disease. The Ingenuity products include pathways analysis software and knowledge bases for biologists and bioinformaticians, and enterprise knowledge management infrastructure, content and services for leading pharmaceutical and biotech companies. Ingenuity was founded in 1998 and is headquartered in Redwood City, California with offices in Germany, Switzerland, France, the United Kingdom, and Japan.